# Monitoring the Effects of Probiotic Supplementation in Immunocompromised Kidney Transplanted Subjects

> **NCT05102461** · NA · WITHDRAWN · sponsor: **State University of New York - Upstate Medical University**

## Conditions studied

- Diarrhea Caused by Drug
- Dysbiosis

## Interventions

- **DIETARY_SUPPLEMENT:** Florajen Digestion Supplementation
- **DIETARY_SUPPLEMENT:** Placebo Supplementation

## Key facts

- **NCT ID:** NCT05102461
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-07
- **Primary completion:** 2022-10
- **Final completion:** 2025-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** It wasn't approved for using Florajen as a dietary supplement and the supplier did not support the application for an IND
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05102461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05102461, "Monitoring the Effects of Probiotic Supplementation in Immunocompromised Kidney Transplanted Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05102461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*